Drug before surgery aims to shrink advanced kidney tumors
NCT ID NCT00715442
Summary
This study is testing if taking the drug sunitinib before surgery helps control advanced kidney cancer that has spread. Fifty patients who are eligible for surgery to remove their primary kidney tumor will take sunitinib for four weeks, have surgery, and then continue the drug. Researchers want to see if this approach delays cancer progression and is safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.